Financhill
Back

Calidi Biotherapeutics Stock Predictions

Calidi Biotherapeutics Stock Forecast

  • Is Calidi Biotherapeutics Stock Undervalued?
    The current Calidi Biotherapeutics [CLDI] share price is $1.90. The Score for CLDI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CLDI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Calidi Biotherapeutics Stock Go Up Next Year?

Data Unavailable

Calidi Biotherapeutics Stock Rating

Data Unavailable

Calidi Biotherapeutics Stock Price History

Is CLDI stock going to rise?

  • The current trend is moderately bearish and CLDI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
calidibio.com

52-Week Data

52-Week High:
24.00
52-Week Low:
0.73

Prediction Charts

Market Cap:
33.28M
Price in USD:
1.90
Volume:
667.97K
Beta:
1.08

Technical Analysis

SMA50:
1.59
SMA100:
1.47
SMA200:
2.40
52-Wk Change:
-91.36%

Stock Predictions

  • Is Calidi Biotherapeutics stock public?
    Yes, Calidi Biotherapeutics is a publicly traded company.
  • What is the Calidi Biotherapeutics stock quote today?
    The Calidi Biotherapeutics stock price is 1.90 USD today.
  • How to buy Calidi Biotherapeutics stock online?
    You can buy Calidi Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-21 2.19 2.15 2.29 2.02
Nov-22 2.16 2.14 2.20 1.96
Nov-25 2.13 2.02 2.20 1.95
Nov-26 1.99 1.93 2.05 1.86
Nov-27 2.13 2.14 2.30 1.94
Nov-29 2.10 2.12 2.23 2.01
Dec-2 2.13 2.18 2.20 2.07
Dec-3 2.14 2.11 2.17 2.04
Dec-4 2.11 1.94 2.13 1.90
Dec-5 1.99 2.01 2.05 1.94
Dec-6 2.04 2.10 2.17 1.94
Dec-9 2.09 1.93 2.11 1.90
Dec-10 1.91 1.90 2.02 1.82
Dec-11 2.00 1.90 2.01 1.87

Calidi Biotherapeutics Earnings

Data Unavailable

Calidi Biotherapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.72 per share, and an increase next year of $0.29 per share.

* Calidi Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.